EUCTR2009-018016-25-NL进行中（未招募）1 期
Dopamine-serotonin dysbalance in patients with dystonia
Academic Medical Center0 个研究点开始时间: 2010年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 35 years or older
- •Primary focal dystonia diagnosed and treated with botulinetoxin injections in the Academic Medical Center
- •Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Other forms of dystonia
- •SSRI use in the past 6 months prior to or during the study
- •Use of other anti-depressants during the study, especially MAO-B inhibitors
- •Symptomatic therapy for dystonia other than botulinetoxin, e.g. baclofen or other muscle relaxants.
- •Use of medication with a known effect on dopamine or serotonin receptors or transporters or with a known interaction with Escitalopram (e.g. L-DOPA, dopamine-agonists, ritalin, NSAID’s, aspirin, tryptophan, carbamazepine, etcetera)
- •Pregnancy or nursing
研究者
相似试验
已完成
3 期
Dopamine-serotonin dysbalance and the relation to myoclonus and psychiatric co-morbidity in patients with dystoniaNL-OMON34645Academisch Medisch Centrum83
已完成
不适用
Dopamine/serotonin dysbalance in dystonia.NL-OMON23462Academic Medical Center, University of Amsterdam68
已完成
不适用
The dopaminergic system in patients with functional dyspepsia analyzed by an alpha-methyl-para-tyrosine (AMPT) challenge test and single photon emission computed tomography (SPECT) imaging before and after treatment with amitriptylineDyspepsiaFunctional dyspepsia (FD)Digestive SystemISRCTN63226989Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)60
招募中
1 期
A Phase 3, prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center study of rotigotine in combination with rivastigmine in mild to moderate Alzheimer’s diseaseMild to moderate Alzheimer's diseaseMedDRA version: 20.0Level: LLTClassification code: 10001896Term: Alzheimer's disease Class: 10029205CTIS2023-504602-11-00Fondazione Santa Lucia IRCCS348
未知
2 期
Dopamine D2 Receptor Occupancy in Patients with Schizophrenia Treated with DSP-5423P Using PET.SchizophreniaJPRN-jRCT2080221869Dainippon Sumitomo Pharma Co., Ltd.20